GHRL

Ghrelin

Hormones

What is Ghrelin?

Ghrelin is a 28-amino acid peptide hormone produced predominantly by enteroendocrine cells (P/D1 cells) in the gastric fundus. Discovered in 1999, ghrelin is unique among gut hormones as the only known peripherally produced orexigenic (appetite-stimulating) hormone—earning it the nickname "hunger hormone." Ghrelin levels rise before meals and fall after eating, creating a preprandial peak that drives meal initiation. Ghrelin exists in two forms: acylated (active) ghrelin, which has a fatty acid chain attached by the enzyme GOAT (ghrelin O-acyltransferase), and desacyl ghrelin, which lacks this modification.

Beyond appetite regulation, ghrelin stimulates growth hormone (GH) release from the anterior pituitary (it was originally identified as the endogenous ligand of the GH secretagogue receptor), promotes gastric motility, has cardioprotective effects, modulates stress and anxiety responses, and influences glucose metabolism. Ghrelin and leptin function as complementary signals in energy homeostasis: ghrelin rises with energy deficit to stimulate feeding, while leptin rises with energy surplus to inhibit it.

Why It Matters

Ghrelin is relevant to understanding obesity, eating disorders, and post-surgical metabolic changes. After gastric bypass surgery, ghrelin levels decrease significantly—thought to contribute to the dramatic appetite suppression and weight loss following the procedure. In Prader-Willi syndrome, a genetic disorder causing severe obesity, ghrelin levels are markedly elevated and may drive the characteristic insatiable appetite. Ghrelin also increases before meals in a learned pattern, contributing to meal-time hunger, and rises during weight loss, potentially promoting weight regain. Research into ghrelin-targeted therapies for obesity, cachexia, and gastroparesis is ongoing.

Normal Reference Ranges

GroupRangeUnit
Fasting (total ghrelin)300–900pg/mL
Post-meal (total ghrelin)100–400pg/mL

Reference ranges may vary by laboratory. Always compare results to the ranges provided by your testing facility.

What High GHRL Levels Mean

Common Causes

  • Prader-Willi syndrome
  • Anorexia nervosa (compensatory increase)
  • Fasting or caloric restriction
  • Weight loss (physiological rise)
  • Cachexia (cancer, chronic illness)
  • Celiac disease
  • Helicobacter pylori infection (eradication raises ghrelin)

Possible Symptoms

  • Intense hunger and food-seeking behavior
  • Increased appetite and hyperphagia
  • Weight gain (if food is available)
  • Increased gastric motility and stomach growling
  • Growth hormone stimulation
  • Often part of the underlying condition rather than ghrelin excess per se

What to do: Elevated ghrelin is usually a physiological response to energy deficit (fasting, weight loss, anorexia) or a feature of a known genetic condition (Prader-Willi syndrome). In Prader-Willi syndrome, management of hyperphagia requires environmental controls (food security, structured eating), behavioral interventions, and ongoing research into pharmacological approaches. In anorexia nervosa, elevated ghrelin reflects the body's attempt to stimulate eating and normalizes with nutritional rehabilitation. In post-weight-loss patients, persistently elevated ghrelin may contribute to weight regain—strategies include high-protein meals (which suppress ghrelin more than carbohydrates), regular meal timing, and adequate sleep.

What Low GHRL Levels Mean

Common Causes

  • Obesity (ghrelin is inversely correlated with body weight)
  • Post-gastric bypass surgery (especially Roux-en-Y)
  • Post-sleeve gastrectomy (removal of ghrelin-producing fundus)
  • Short bowel syndrome
  • Helicobacter pylori gastritis (some studies)
  • Growth hormone excess (acromegaly)

Possible Symptoms

  • Reduced appetite and early satiety
  • Weight loss (post-surgical)
  • Decreased motivation to eat
  • Altered meal patterns
  • Often asymptomatic—low ghrelin in obesity is appropriate

What to do: Low ghrelin in obesity is a physiological adaptation and does not require treatment—the problem in obesity is not insufficient hunger signaling. After bariatric surgery, low ghrelin contributes beneficially to appetite suppression and weight loss. If appetite loss is problematic (cachexia, failure to thrive in elderly), ghrelin agonists are being investigated. Anamorelin, a ghrelin receptor agonist, is approved in some countries for cancer-related cachexia and has shown improvement in appetite, lean body mass, and quality of life.

When Is GHRL Testing Recommended?

  • When evaluating suspected Prader-Willi syndrome
  • In research protocols studying appetite regulation and obesity
  • When assessing metabolic changes after bariatric surgery
  • When investigating unexplained severe hyperphagia

Frequently Asked Questions

Ghrelin exhibits a learned, anticipatory pattern of secretion. Levels rise in the hours before habitual mealtimes and drop sharply after eating. This pattern is entrained by regular meal schedules—if you consistently eat lunch at noon, ghrelin begins rising around 11 AM. If meal timing is shifted, the ghrelin pattern adjusts over several days. The preprandial ghrelin surge stimulates hunger, increases gastric motility (preparing the stomach for food), and promotes GH secretion. After eating, the presence of nutrients in the gut—particularly carbohydrates and protein—suppresses ghrelin secretion. This explains why skipping meals produces strong hunger: ghrelin continues to rise without the post-meal suppression signal.
Different bariatric procedures have different effects on ghrelin. Roux-en-Y gastric bypass (RYGB) significantly reduces ghrelin levels, likely because the procedure bypasses the gastric fundus (the primary ghrelin-producing region) and alters its blood supply. Sleeve gastrectomy physically removes approximately 80% of the stomach including most of the fundus, causing a dramatic and permanent reduction in ghrelin levels. Gastric banding, which does not alter gastric anatomy, has minimal effects on ghrelin. The reduction in ghrelin after bypass and sleeve procedures is thought to be one mechanism contributing to the superior appetite suppression and sustained weight loss seen with these procedures compared to banding or dietary restriction alone.
Ghrelin and sleep are bidirectionally linked. Sleep deprivation increases ghrelin levels and decreases leptin, creating a hormonal milieu that promotes hunger and overeating—this is one explanation for the well-documented association between short sleep duration and obesity. Studies show that sleeping only 4–5 hours per night for just two nights increases ghrelin by approximately 28% and hunger ratings by 24%, with increased craving for calorie-dense, carbohydrate-rich foods. Conversely, ghrelin promotes sleep—ghrelin administration increases slow-wave sleep (deep sleep) in humans. The relationship is part of a broader connection between metabolic hormones and sleep architecture, and highlights the importance of adequate sleep for weight management.

Related Biomarkers

LEPLeptinInsulinInsulinGHGrowth HormoneGLUGlucose

Want your GHRL levels analyzed?

Upload your lab results for an instant AI-powered breakdown of all your biomarkers.

Upload Lab Results →

Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Reference ranges may vary between laboratories. Always consult your healthcare provider for interpretation of your specific test results.

Disclaimer: SymptomGPT is not a medical diagnosis tool and does not provide medical advice. Always consult a qualified healthcare professional. If you are experiencing a medical emergency, call 911 immediately.